VOYAGER THERAPEUTICS INC reports a Return on Equity (ROE) of -67.16%.

What is VYGR's dividend yield?

VOYAGER THERAPEUTICS INC offers a dividend yield of 0.00%.

What is VYGR's Deepscope Quality Score?

Deepscope rates VYGR's overall financial quality at 0 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy VYGR?

Deepscope's AI Timing Score for VYGR is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does VYGR belong to?

VOYAGER THERAPEUTICS INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

VYGR (NASDAQ) Stock Analysis | VOYAGER THERAPEUTICS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

VYGR

VOYAGER THERAPEUTICS INC

US:NASDAQ STOCK Healthcare >> Biotechnology News 99

USD 3.33

-0.29 (-8.01%) Day Change

Watchlist Portfolio Compare Chart

0.04

D/E

-67.2%

ROE

-53.2%

ROA

0.00%

Div Yield

VOYAGER THERAPEUTICS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 3.33 Price -0.29 (-8.01%) Day Change	NEWS SCORE: 99

VYGR, the overall quality is not good ( Quality = 0) and the timing to buy is ...(Sign In to See)...

Loading chart...

0 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	99
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	3.33
PBV / Sector	1.16 / 4.63 GREAT
Earning Per Share	-1.93

PE / Sector	N/A / 17.43
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	2.24 M GREAT
Average 1W Daily Value	1.95 M GREAT

Timing Factors

14%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-319.61 / 449.48
NPM Average (%) / Sector	-151.58 / -1,506.49
NPM Change Average (%) / Sector	-31.86 / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-53.18 / 30.58
ROA Average (%) / Sector	-21.73 / -347.17
ROA Change Average (%) / Sector	-43.56 / 5,125.52
ROE (%) / Sector	-67.16 / -3.58
ROE Average (%) / Sector	-34.51 / 40.65
ROE Change Average (%) / Sector	-29.59 / 2,109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

Registration Details

Analyze Date	2026-06-06 09:09:19
Symbol	VYGR
Name	VOYAGER THERAPEUTICS INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	60.42 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	201.20 / 8,857.28

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 75 Hayden Avenue, Lexington, MA, United States, 02421

Phone: 857 259 5340

Website: https://www.voyagertherapeutics.com

Employees: 141

Sector: Healthcare >> Biotechnology

Description: Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.